DUBOIS, MARCO
 Distribuzione geografica
Continente #
EU - Europa 9.462
NA - Nord America 279
AS - Asia 105
OC - Oceania 2
Totale 9.848
Nazione #
IT - Italia 9.356
US - Stati Uniti d'America 273
SE - Svezia 56
CN - Cina 43
SG - Singapore 20
IN - India 15
NL - Olanda 11
DE - Germania 9
FI - Finlandia 8
GB - Regno Unito 8
FR - Francia 7
HK - Hong Kong 7
CA - Canada 5
TH - Thailandia 4
VN - Vietnam 4
GR - Grecia 3
IR - Iran 3
JP - Giappone 3
KR - Corea 3
AU - Australia 2
IE - Irlanda 2
ES - Italia 1
IL - Israele 1
MO - Macao, regione amministrativa speciale della Cina 1
RU - Federazione Russa 1
TR - Turchia 1
TT - Trinidad e Tobago 1
Totale 9.848
Città #
Cagliari 9.262
Uta 54
Nyköping 48
Fairfield 39
Chandler 35
Ashburn 24
Boardman 24
Houston 14
Shanghai 14
New York 12
Seattle 12
Pune 11
San Diego 11
Singapore 11
Woodbridge 11
Boston 10
Rome 10
Wilmington 9
Amsterdam 8
Helsinki 8
Cambridge 6
Los Angeles 6
Toronto 5
Dong Ket 4
Hefei 4
Hong Kong 4
Menlo Park 4
Romainville 4
Nakano 3
Peristeri 3
San Cipriano d'Aversa 3
Seoul 3
Delhi 2
Don Mueang 2
Guangzhou 2
Islington 2
Jiaxing 2
London 2
Naples 2
Olbia 2
Paris 2
San Francisco 2
San Giorgio a Cremano 2
Shenzhen 2
Sydney 2
Xian 2
Alexandria 1
Amgaon 1
Ankara 1
Ann Arbor 1
Bilbao 1
Chandigarh 1
Clifton 1
Dongyang 1
Exeter 1
Frattamaggiore 1
Hamburg 1
Hangzhou 1
Heidelberg 1
Jacksonville 1
Jinhua 1
Miami Beach 1
Moscow 1
Naaldwijk 1
Nanjing 1
New Bedfont 1
Norwalk 1
Pisa 1
Port-of-spain 1
Portland 1
Pozzuoli 1
Rockville 1
Somerville 1
South Deerfield 1
Stockholm 1
Tabriz 1
Trumbull 1
Washington 1
Wuhan 1
Zhengzhou 1
Totale 9.738
Nome #
Molecular-biology-driven treatment for metastatic colorectal cancer 2.534
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 1.172
Molecular-driven treatment for biliary tract cancer: the promising turning point 1.033
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors 738
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 714
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment 662
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression 547
Uncovering key targets of success for immunotherapy in pancreatic cancer 519
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus 502
The role of immune checkpoint inhibitors in the treatment sequence of advanced gastric or gastro-esophageal junction cancer: A systematic review and meta-analysis of randomized trials 481
BRCA-mutant pancreatic ductal adenocarcinoma 423
Immune Checkpoint Inhibitors in the Treatment of HCC 413
Clinical score for colorectal cancer patients with lung-limited metastases undergoing surgical resection: Meta-Lung Score 109
Thyroid dysfunction and immune checkpoint inhibitors: Effect on survival in elderly patients 48
Totale 9.895
Categoria #
all - tutte 14.452
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.452


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021959 0 0 1 330 197 120 40 64 35 70 49 53
2021/20221.147 53 48 3 25 40 84 56 120 69 95 188 366
2022/20232.498 275 375 260 167 184 233 115 157 164 292 182 94
2023/20241.946 79 56 80 107 166 354 365 160 97 97 186 199
2024/20253.345 1.486 1.641 218 0 0 0 0 0 0 0 0 0
Totale 9.895